Home › Funds › BALDWIN WEALTH PARTNERS LLC/MA › AXSM

BALDWIN WEALTH PARTNERS LLC/MA position in AXSM

AXSOME THERAPEUTICS INC. · Health Care

BALDWIN WEALTH PARTNERS LLC/MA reported holding 44,070 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.54% of its reported portfolio and ranking #41 among its reported holdings. BALDWIN WEALTH PARTNERS LLC/MA has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)44.07K sh
Reported value held$8.13M
Portfolio Weight0.54%
First reportedQ3 2023
Last changeHold
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How BALDWIN WEALTH PARTNERS LLC/MA's AXSM position evolved

BALDWIN WEALTH PARTNERS LLC/MA first disclosed a stake in AXSM in Q3 2023 at 47,995 shares (US$3.4M). The position peaked in Q2 2026 at 44,070 shares, worth US$10.8M. Across 13 filings, BALDWIN WEALTH PARTNERS LLC/MA increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 44,070 shares valued at US$8.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 47.99K $3.35M New
Q4 2023 48.99K $3.90M Add
Q1 2024 49.70K $3.97M Add
Q2 2024 49.70K $4.00M Hold
Q3 2024 49.70K $4.47M Hold
Q4 2024 49.57K $4.19M Hold
Q1 2025 49.57K $5.78M Hold
Q2 2025 48.57K $5.07M Reduce
Q3 2025 48.57K $5.90M Hold
Q4 2025 48.57K $8.87M Hold
Q1 2026 42.07K $7.11M Reduce
Q2 2026 44.07K $10.79M Add
Q3 2026 44.07K $8.13M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AXSM and 13F data

AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 54 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$158.8M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AXSM

All AXSM fund holders →

FAQ

How long has BALDWIN WEALTH PARTNERS LLC/MA held AXSM?

BALDWIN WEALTH PARTNERS LLC/MA has disclosed AXSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BALDWIN WEALTH PARTNERS LLC/MA's current position in AXSM?

As of Q3 2026, BALDWIN WEALTH PARTNERS LLC/MA holds 44.07K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.13M, representing 0.54% of its reported portfolio and ranking #41.

Has BALDWIN WEALTH PARTNERS LLC/MA been buying or selling AXSM?

In the latest 13F filing (Q3 2026), BALDWIN WEALTH PARTNERS LLC/MA held unchanged its position in AXSM. The position peaked in Q2 2026 at 44.07K shares.

Which other funds hold AXSM?

Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.